Huapont Life Sciences Co Ltd
SZSE:002004

Watchlist Manager
Huapont Life Sciences Co Ltd Logo
Huapont Life Sciences Co Ltd
SZSE:002004
Watchlist
Price: 5.17 CNY 0.58% Market Closed
Market Cap: ¥10.2B

Huapont Life Sciences Co Ltd
Research & Development

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Huapont Life Sciences Co Ltd
Research & Development Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
Huapont Life Sciences Co Ltd
SZSE:002004
Research & Development
-¥355.6m
CAGR 3-Years
3%
CAGR 5-Years
-5%
CAGR 10-Years
N/A
Yunnan Yuntianhua Co Ltd
SSE:600096
Research & Development
-¥706.1m
CAGR 3-Years
-27%
CAGR 5-Years
-57%
CAGR 10-Years
-33%
Shandong Hualu-Hengsheng Chemical Co Ltd
SSE:600426
Research & Development
-¥882.9m
CAGR 3-Years
-13%
CAGR 5-Years
-25%
CAGR 10-Years
-25%
Qinghai Salt Lake Industry Co Ltd
SZSE:000792
Research & Development
-¥82.5m
CAGR 3-Years
30%
CAGR 5-Years
-3%
CAGR 10-Years
-26%
Zangge Mining Co Ltd
SZSE:000408
Research & Development
-¥22.9m
CAGR 3-Years
-2%
CAGR 5-Years
-20%
CAGR 10-Years
N/A
Asia Potash International Investment Guangzhou Co Ltd
SZSE:000893
Research & Development
-¥18.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Huapont Life Sciences Co Ltd
Glance View

Market Cap
10.2B CNY
Industry
Chemicals

Huapont Life Sciences Co., Ltd., a prominent player in the global pharmaceutical and agrochemical sector, finds its roots in the bustling city of Chongqing, China. Established in 1992, the company swiftly evolved from a regional upstart to a substantial force in the life sciences industry. Huapont's narrative is grounded in its strategic blend of pharmaceutical prowess and agrochemical dexterity. The company's pharmaceutical operations primarily focus on the development, production, and marketing of dermatological and anti-tuberculosis drugs, riding on China's expansive healthcare reforms and increasing demand for specialized medical treatments. This niche approach allows Huapont to capture a substantial share of the market, offering innovative solutions that cater to rising public health concerns. Parallel to its medical endeavors, Huapont has cultivated a robust agrochemical arm. The company leverages advanced research and development to produce and distribute a wide range of crop protection products, including herbicides, fungicides, and insecticides. This diversification in agrochemicals keeps Huapont resilient amidst agricultural cycles and global market fluctuations, providing a steady stream of revenue. By interweaving pharmaceutical advancements with agricultural science, Huapont effectively taps into two essential human needs: health and sustenance. Through these dual pillars, the company harmoniously balances its portfolio, drawing upon scientific research and market insights to drive sustainable growth and enduring value for its stakeholders.

Intrinsic Value
6.35 CNY
Undervaluation 19%
Intrinsic Value
Price ¥5.17

See Also

What is Huapont Life Sciences Co Ltd's Research & Development?
Research & Development
-355.6m CNY

Based on the financial report for Sep 30, 2025, Huapont Life Sciences Co Ltd's Research & Development amounts to -355.6m CNY.

What is Huapont Life Sciences Co Ltd's Research & Development growth rate?
Research & Development CAGR 5Y
-5%

Over the last year, the Research & Development growth was 10%. The average annual Research & Development growth rates for Huapont Life Sciences Co Ltd have been 3% over the past three years , -5% over the past five years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett